| INTRODUCTION
The prevalence rates of obesity and type 2 diabetes have increased concomitantly in the USA during the last 30 years. [1] [2] [3] Obesity, and in particular abdominal obesity, is also a major risk factor for type 2 diabetes, 4, 5 suggesting that the increase in the prevalence of obesity has contributed, at least in part, to the increase in the prevalence of type 2 diabetes. The aims of the present study were to assess the trends in the prevalence of type 2 diabetes and abdominal obesity in the USA from 1999 to 2014, and to examine whether the trends in the prevalence of type 2 diabetes differ between abdominally obese and non-obese individuals. Our hypothesis was that the association between obesity and type 2 diabetes was contributing to growing health *J.J.S. was employed by AstraZeneca at the time that the work was conducted and his current affiliation is Janssen Scientific Affairs, LLC, Titusville, New Jersey.
disparities and could justify more focused primary prevention programmes, for instance, targeting US residents presenting with obesity.
| METHODS
The National Health and Nutrition Examination Survey (NHANES) is a programme of studies designed to assess the health and nutritional status of adults and children in the USA. It has been conducted by the Centers for Disease Control and Prevention since the early 1960s. Beginning in 1999, every 2 years, NHANES examined a nationally representative sample of~10 000 individuals from the resident, civilian, non-institutionalized US population. The survey consisted of an interview conducted in the home, followed the next day by a standardized health examination in specially equipped mobile examination centres that included a physical examination administered by trained medical personnel as well as laboratory tests.
Whole-blood specimens were drawn from all participants aged ≥12 years, then processed and stored under appropriate refrigerated 
| RESULTS
The size of the resident, non-institutionalized population of the USA (Table S1) (Table S2 ).
The prevalence of type 2 diabetes and abdominal obesity (Table 1) Our operational definition for type 2 diabetes, previous diagnosis by a healthcare practitioner or HbA1c ≥6.5%, differs from other publications that analysed NHANES data, and also took into account a fasting blood glucose >125 mg/dL and a 2-hour post-load plasma glucose measurement ≥200 mg/dL. 1,6,7 Accordingly, our prevalence estimates for diabetes by age group are slightly lower than those recently published using data from NHANES 2011/2012
and 2013/2014. 1, 7 We retained this definition because fasting blood We retained obesity as measured by waist circumference rather than by BMI because abdominal obesity has been described as a stronger independent predictor, not only of cardiovascular events 8 and mortality, 9 but also of type 2 diabetes 5,10 ; however, we observed the same association between type 2 diabetes and obesity measured by There is a trend towards an increase in the prevalence of type 2 diabetes in non-obese individuals aged ≥65 years, with a mean increase per year of 0.23% (95% CI -0.08 to 0.54). This trend remains non-significant (P = .15), perhaps because our study was underpowered, although a total of 3206 non-obese individuals aged ≥65 years were retained for analysis.
The absence of any significant increase in the prevalence of type 2 diabetes in all participants aged 20 to 44 years also needs to be interpreted with caution as other studies have found a significant increase among young adults, not only in type 1 but also in type 2 diabetes. 14, 15 The stable prevalence of type 2 diabetes among individuals without abdominal obesity suggests minimal exposure to changing lifestyle risk factors among this group. Conversely, the increasing prevalence of type 2 diabetes in the obese population can be partly and smoking status, which were not analysed in this study.
Growing disparities in the risk of type 2 diabetes have been observed not only as a function of abdominal obesity and age but also geographically, with widening differences in the prevalence of diabetes among US counties from 2004 and 2012. 16 These disparities highlight the cumulative effect of risk factors in fragile populations and reinforce the rationale for focused primary prevention programmes.
In conclusion, the present findings highlight the critical importance of abdominal obesity, both as a key contributor to the continuing epidemic of type 2 diabetes in the USA, and as a high-priority target for potential public health interventions. The burden of type 2 diabetes can be controlled, in part, by better management of its complications. Although some progress has been made in this direction, 17 these results are achieved at a high financial cost. The burden of type 2 diabetes could also be controlled by primary prevention efforts and public health interventions that target modifiable risk factors: this study supports the prioritization of these efforts in the population with abdominal obesity.
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